Recent studies have shown that disrupting Tim-3 expression in clear cell renal cell carcinoma can reduce cancer invasion by enhancing anoikis (a form of programmed cell death), identifying Tim-3 as a potential therapeutic target [145]. The gene discussed is HAVCR2; the disease is cancer.